Equities

Creo Medical Group PLC

CREO:LSE

Creo Medical Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)17.75
  • Today's Change0.25 / 1.43%
  • Shares traded1.42m
  • 1 Year change-4.05%
  • Beta1.2030
Data delayed at least 20 minutes, as of Feb 06 2026 16:17 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Creo Medical Group PLC's net income fell 32.26% from a loss of 21.70m to a larger loss of 28.70m despite flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 42.50% to 52.50%.
Gross margin45.45%
Net profit margin572.73%
Operating margin559.09%
Return on assets18.25%
Return on equity23.27%
Return on investment20.62%
More ▼

Cash flow in GBPView more

In 2024, Creo Medical Group PLC increased its cash reserves by 310.00%, or 9.30m. Cash Flow from Financing totalled 16.20m or 405.00% of revenues. In addition the company used 22.20m for operations while cash from investing totalled 15.30m.
Cash flow per share0.0351
Price/Cash flow per share5.27
Book value per share0.1477
Tangible book value per share0.146
More ▼

Balance sheet in GBPView more

Creo Medical Group PLC has a Debt to Total Capital ratio of 6.45%, a lower figure than the previous year's 22.57%.
Current ratio5.28
Quick ratio4.75
Total debt/total equity0.069
Total debt/total capital0.0645
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.